Literature DB >> 32430947

Substituting imputation of HLA antigens for high-resolution HLA typing: Evaluation of a multiethnic population and implications for clinical decision making in transplantation.

Rachel M Engen1, Aneta M Jedraszko2, Michael A Conciatori3, Anat R Tambur3.   

Abstract

Molecular mismatch analysis for assessment of histocompatibility in transplantation requires high-resolution HLA typing. Algorithms to "guesstimate" high-resolution from low-resolution typing exist, but their accuracy remains unknown. We converted high-resolution, sequence-based, HLA typing of 310 subjects from an ethnically heterogeneous population to low-resolution equivalents and tested the ability of the NMDP HaploStats and HLA Matchmaker programs to impute/reproduce the measured high-resolution HLA type, using the more common "winner-takes-all" approach. Only 35.6% of the HaploStats imputed HLA-A, -B, -C, -DRB1, and -DQB1 haplotypes had no mistakes, and the accuracy was significantly lower for non-Caucasians (29.1%) compared to Caucasians (45.2%) (odds ratio [OR], 0.5; 95% confidence interval [CI], 0.3-0.8; P = .004). HLA Matchmaker was not able to provide high-resolution haplotypes for 45.2% of Caucasian subjects and 63.5% of non-Caucasian subjects (P = .002). Of those with an imputed result, only 10.3% of Caucasians and 4.8% of non-Caucasians had accurate 10-allele high-resolution output. Eplet analysis revealed additional, inaccurate eplets in 37% of individuals, with 22.5% showing at least 2 additional, inaccurate eplets; incorrect eplets were more common among non-Caucasians (OR, 1.8; 95% CI, 1.1-2.9; P = .018). Given this high error rate, caution should be taken before using imputation tools for clinical or research purposes, especially for non-Caucasian individuals.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/ practice; histocompatibility; kidney transplantation/ nephrology; major histocompatibility complex (MHC); organ allocation; organ procurement and allocation; risk assessment/ risk stratification

Mesh:

Substances:

Year:  2020        PMID: 32430947     DOI: 10.1111/ajt.16070

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

Review 1.  Pediatric Kidney Transplantation-Can We Do Better? The Promise and Limitations of Epitope/Eplet Matching.

Authors:  Olga Charnaya; Daniella Levy Erez; Sandra Amaral; Dimitrios S Monos
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

2.  Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients.

Authors:  Hyeyoung Lee; Ji Won Min; Hyunhye Kang; Hanbi Lee; Sang Hun Eum; Yohan Park; Chul Woo Yang; Byung Ha Chung; Eun-Jee Oh
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

3.  Clinical Significance of Shared T Cell Epitope Analysis in Early De Novo Donor-Specific Anti-HLA Antibody Production After Kidney Transplantation and Comparison With Shared B cell Epitope Analysis.

Authors:  Toshihide Tomosugi; Kenta Iwasaki; Shintaro Sakamoto; Matthias Niemann; Eric Spierings; Isao Nahara; Kenta Futamura; Manabu Okada; Takahisa Hiramitsu; Asami Takeda; Norihiko Goto; Shunji Narumi; Yoshihiko Watarai; Takaaki Kobayashi
Journal:  Front Immunol       Date:  2021-03-26       Impact factor: 8.786

4.  Editorial: Future challenges and directions in determining allo-immunity in kidney transplantation.

Authors:  Wai H Lim; Julie Ho; Vasilis Kosmoliaptsis; Ruth Sapir-Pichhadze
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

5.  On the clinical relevance of using complete high-resolution HLA typing for an accurate interpretation of posttransplant immune-mediated graft outcomes.

Authors:  Maria Meneghini; Anna Perona; Elena Crespo; Frederike Bemelman; Petra Reinke; Ondrej Viklicky; Magali Giral; Eduard Palou; Alba Torija; Laura Donadeu; Edoardo Melilli; Jose Zuñiga; Anett Sefrin; Nils Lachmann; Liu Hu; Petra Hruba; Cécile Guillot-Gueguen; Sophie Brouard; Josep Grinyo; Oriol Bestard
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

6.  On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss.

Authors:  Hossein Mohammadhassanzadeh; Karim Oualkacha; Wenmin Zhang; William Klement; Amelie Bourdiec; Jennat Lamsatfi; Yang Yi; Bethany Foster; Paul Keown; Howard M Gebel; Frans Claas; Ruth Sapir-Pichhadze
Journal:  Kidney Int Rep       Date:  2021-03-30

7.  Analysis of T and B Cell Epitopes to Predict the Risk of de novo Donor-Specific Antibody (DSA) Production After Kidney Transplantation: A Two-Center Retrospective Cohort Study.

Authors:  Shintaro Sakamoto; Kenta Iwasaki; Toshihide Tomosugi; Matthias Niemann; Eric Spierings; Yuko Miwa; Kosei Horimi; Asami Takeda; Norihiko Goto; Shunji Narumi; Yoshihiko Watarai; Takaaki Kobayashi
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.